INDICATIONS AND USAGE
ACTIMMUNE® (Interferon gamma-1b) is indicated:
Provide protection with ACTIMMUNE, the only FDA-approved therapy indicated for reducing the frequency and severity of serious infections* associated with chronic granulomatous disease (CGD).2,3
Learn about common side effects and how to manage them.
Speak with a representative about testing for and treating CGD.
Access case studies, practice tools, and downloadable patient materials.
For US Healthcare Professionals
*Serious infection is defined as a clinical event requiring hospitalization and/or intravenous antibiotics.
ACTIMMUNE® (Interferon gamma-1b) is indicated:
Please see Full Prescribing Information for additional safety information.
ACTIMMUNE® (Interferon gamma-1b) is indicated:
ACTIMMUNE® (Interferon gamma-1b) is indicated:
ACTIMMUNE® (Interferon gamma-1b) is indicated:
Please see Full Prescribing Information for additional safety information.